{"id":186636,"name":"GLAXOSMITHKLINE","slug":"glaxosmithkline","state":"DC","description":"&#226;€‹Biotechnology pharmaceutical product discovery and development.","totalSpending":1290000,"filings":26,"yearlySpending":[{"year":2018,"income":190000},{"year":2019,"income":250000},{"year":2020,"income":250000},{"year":2021,"income":100000},{"year":2022,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":100000}],"firms":["JST STRATEGIES LLC (JOCHUM SHORE & TROSSEVIN PC)"],"lobbyists":["DARIN GARDNER","ANDREW SHORE","JAMES JOCHUM","AMBER FAHY","MICHAEL KATZ","EMILY VAUGHAN"],"issues":["BUD","HCR"],"sampleDescriptions":["Advocacy for expanded access to vaccines.  Advocacy for lupus research within the Department of Defense.  Funding for biosecurity and medical countermeasures.","Part D prescription drug benefit","Drug pricing issues","Drug pricing issues and Operation Warp Speed","drug pricing","Issues related to drug pricing","Prescription drug pricing issues"],"years":[2018,2019,2020,2021,2022,2024,2025]}